Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-001827
Filing Date
2022-01-05
Accepted
2022-01-05 17:26:14
Documents
1
Period of Report
2022-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4023
  Complete submission text file 0001209191-22-001827.txt   5409
Mailing Address 11099 TORREY PINES PARK ROAD SAN DIEGO CA 92037
Business Address 11099 TORREY PINES PARK ROAD SAN DIEGO CA 92037 858-750-4700
Janux Therapeutics, Inc. (Issuer) CIK: 0001817713 (see all company filings)

IRS No.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O JANUX THERAPEUTICS, INC. 11099 N. TORREY PINES ROAD, SUITE 290 LA JOLLA CA 92037
Business Address
Meyer Andrew Hollman (Reporting) CIK: 0001864159 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40475 | Film No.: 22512407